Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;56(1):3-16.
doi: 10.1007/s13139-021-00727-1. Epub 2022 Jan 15.

60 Years of Achievements by KSNM in Neuroimaging Research

Affiliations
Review

60 Years of Achievements by KSNM in Neuroimaging Research

Jae Seung Kim et al. Nucl Med Mol Imaging. 2022 Feb.

Abstract

Nuclear medicine neuroimaging is able to show functional and molecular biologic abnormalities in various neuropsychiatric diseases. Therefore, it has played important roles in the clinical diagnosis and in research on the normal and pathological states of the brain. More than 400 outstanding studies have been conducted by Korean researchers over the past 60 years. In the 1990s, when multiheaded single-photon emission computed tomography (SPECT) scanners were first introduced in South Korea, stroke research using brain perfusion SPECT was conducted. With the spread of positron emission tomography (PET) scanners in the 2000s, research on the clinical usefulness of PET and the evaluation of pathophysiology in various diseases such as epilepsy, brain tumors, degenerative brain diseases, and other neuropsychiatric diseases were actively conducted using [18F]FDG and various neuroreceptor tracers. In the 2010s, with the clinical application of new radiopharmaceuticals for amyloid and tau imaging, research demonstrating the clinical usefulness of PET imaging and the pathophysiology of dementia has increased rapidly. It is expected that the role of nuclear medicine will expand with the development of new radiopharmaceuticals and analysis technologies, along with the application of artificial intelligence for early and differential diagnosis, and the development of therapeutic agents for degenerative brain diseases.

Keywords: Brain; KSNM; PET; Research; SPECT.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestJae Seung Kim, Hye Joo Son, Minyoung Oh, Dong Yun Lee, Hae Won Kim, and Jungsu Oh declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
The number of papers published in each research field of nuclear medicine neuroimaging by Korean researchers over the past 60 years

Similar articles

Cited by

References

    1. Hyun Y, Lee JS, Rha JH, Lee IK, Ha CK, Lee DS. Different uptake of 99mTc-ECD and 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping. Eur J Nucl Med. 2001;28:191–197. - PubMed
    1. Yoon BW, Roh JK, Myung HJ, Moon DH, Lee MC, Koh CS. Assessment of regional cerebral blood flow (rCBF) in ischemic stroke using Tc-99m HMPAO SPECT-comparison with CT and MR findings. J Korean Med Sci. 1991;6:21–29. - PMC - PubMed
    1. Song HC, Bom HS, Cho KH, Kim BC, Seo JJ, Kim CG, et al. Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with Technetium-99m–labeled metronidazole. Stroke. 2003;34:982–986. - PubMed
    1. Lee G-H, Kim JS, Oh SJ, Kang D-W, Kim JS, Kwon SU. 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) predicts early infarct growth in patients with acute ischemic stroke. J Neuroimaging. 2015;25:652–655. - PubMed
    1. Kim J, Choi KH, Song HC, Kim JT, Park MS, Cho KH. 18F-FDG PET/CT imaging factors that predict ischaemic stroke in cancer patients. Eur J Nucl Med Mol Imaging. 2016;43:2228–2235. - PubMed

LinkOut - more resources